Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen B Wheatcroft

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
BMC Cardiovascular Disorders|October 29, 2022
Safety and efficacy of interrupting dual antiplatelet therapy one month following percutaneous coronary intervention: a meta-analysis of randomized controlled trialsShane Parfrey, Amr Abdelrahman, Daniel Blackman, et al.
Vascular Biology (Bristol, England)|October 14, 2024
Whole-body insulin resistance leads to accelerated atherosclerosis: role for Nox2 NADPH oxidaseAzhar Maqbool, Hema Viswambharan, Anna Skromna, et al.
Biology Open|April 6, 2016
VEGF-A isoforms program differential VEGFR2 signal transduction, trafficking and proteolysisGareth W Fearnley, Gina A Smith, Izma Abdul-Zani, et al.
European Heart Journal. Acute Cardiovascular Care|October 6, 2017
Clinical outcomes following primary percutaneous coronary intervention for ST-elevation myocardial infarction according to sex and raceArvindra Krishnamurthy, Claire Keeble, Natalie Burton-Wood, et al.
Open Heart|October 3, 2022
Association between operator volume and mortality in primary percutaneous coronary interventionArvindra Krishnamurthy, Claire M Keeble, Michelle Anderson, et al.
Diabetes & Vascular Disease Research|April 16, 2024
Diabetes mellitus does not alter mortality or hospitalisation risk in patients with newly diagnosed heart failure with preserved ejection fraction: Time to rethink pathophysiological models of disease progressionJohn Gierula, Sam Straw, Charlotte A Cole, et al.
Diabetes|January 30, 2007
IGF-binding protein-2 protects against the development of obesity and insulin resistanceStephen B Wheatcroft, Mark T Kearney, Ajay M Shah, et al.
Diabetes|February 15, 2011
Insulin resistance impairs circulating angiogenic progenitor cell function and delays endothelial regenerationMatthew B Kahn, Nadira Y Yuldasheva, Richard M Cubbon, et al.
Endocrinology|August 30, 2021
Pericyte Insulin Receptors Modulate Retinal Vascular Remodeling and Endothelial Angiopoietin SignalingNele Warmke, Fiona Platt, Alexander F Bruns, et al.
Diabetes & Vascular Disease Research|January 26, 2013
Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiologyRichard M Cubbon, Brook Adams, Adil Rajwani, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
BMC Cardiovascular Disorders|October 29, 2022
Safety and efficacy of interrupting dual antiplatelet therapy one month following percutaneous coronary intervention: a meta-analysis of randomized controlled trialsShane Parfrey, Amr Abdelrahman, Daniel Blackman, et al.
Vascular Biology (Bristol, England)|October 14, 2024
Whole-body insulin resistance leads to accelerated atherosclerosis: role for Nox2 NADPH oxidaseAzhar Maqbool, Hema Viswambharan, Anna Skromna, et al.
Biology Open|April 6, 2016
VEGF-A isoforms program differential VEGFR2 signal transduction, trafficking and proteolysisGareth W Fearnley, Gina A Smith, Izma Abdul-Zani, et al.
European Heart Journal. Acute Cardiovascular Care|October 6, 2017
Clinical outcomes following primary percutaneous coronary intervention for ST-elevation myocardial infarction according to sex and raceArvindra Krishnamurthy, Claire Keeble, Natalie Burton-Wood, et al.
Open Heart|October 3, 2022
Association between operator volume and mortality in primary percutaneous coronary interventionArvindra Krishnamurthy, Claire M Keeble, Michelle Anderson, et al.
Diabetes & Vascular Disease Research|April 16, 2024
Diabetes mellitus does not alter mortality or hospitalisation risk in patients with newly diagnosed heart failure with preserved ejection fraction: Time to rethink pathophysiological models of disease progressionJohn Gierula, Sam Straw, Charlotte A Cole, et al.
Diabetes|January 30, 2007
IGF-binding protein-2 protects against the development of obesity and insulin resistanceStephen B Wheatcroft, Mark T Kearney, Ajay M Shah, et al.
Diabetes|February 15, 2011
Insulin resistance impairs circulating angiogenic progenitor cell function and delays endothelial regenerationMatthew B Kahn, Nadira Y Yuldasheva, Richard M Cubbon, et al.
Endocrinology|August 30, 2021
Pericyte Insulin Receptors Modulate Retinal Vascular Remodeling and Endothelial Angiopoietin SignalingNele Warmke, Fiona Platt, Alexander F Bruns, et al.
Diabetes & Vascular Disease Research|January 26, 2013
Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiologyRichard M Cubbon, Brook Adams, Adil Rajwani, et al.
Pageof 10